Misplaced Pages

List of Johnson & Johnson products and services

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is a list of products and services provided by Johnson & Johnson (J&J).

Medical technologies

In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision.

  • Heart and Cardiac
  • Cardiac Arrhythmia Diagnosis & Treatment Products (Biosense Webster)
    • Carto 3 System
    • Thermocool Smarttouch SF Catheter
    • Carto Vizigo Bi-Directional Guiding Sheath
    • Pentaray Nav ECO High Density Mapping Catheter
  • Neurovascular (Cerenovus)
    • Embotrap III Revascularization Device
    • Embovac Aspiration Catheter
    • Cerenovus Large Bore Catheter
    • Cerenovus Nimbus
    • Cerebase DA Guide Sheath
    • Trufill n-BCA Liquid Embolic System
  • Orthopedics (DePuy Synthes)
    • Velys Digital Surgery platform
    • Attune Cementless Fixed Bearing Knee
    • Actis Hip Stem
    • Inhance Shoulder System
    • Dynatape Suture
    • Trumatch Graft Cage
    • Symphony OCT System
  • Surgery (Ethicon)
    • Vicryl
    • Echelon stapling products
    • Stratafix knotless tissue devices
    • Surgicel absorbable hemostats
    • Monarch platform
  • Breast augmentation and reconstruction (Mentor)
    • MemoryGel Breast Implants
    • MemoryShape Breast Implants
    • Artoura Breast Tissue Expanders
    • CPX Breast Tissue Expenders
    • Mentor Saline Breast Implants
  • Eye health (Johnson & Johnson Vision)

Pharmaceutical therapies

The company's major franchises in the pharmaceuticals segment include immunology, neuroscience, infectious disease and vaccines, oncology, cardiovascular and metabolism, and pulmonary hypertension.

References

  1. "Medical Devices". Content Lab - U.S.
  2. Whooley, Sean (22 December 2022). "Johnson & Johnson completes $16.6B Abiomed acquisition". MassDevice. WTWH Media.
  3. "First post-approval procedures performed using Heliostar balloon ablation catheter". Cardiac Rhythm News. 2021-09-29. Retrieved 2021-09-30.
  4. "FDA Clears Biosense Webster ThermoCool SmartTouch SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation". DAIC. 2020-10-06. Retrieved 2021-09-30.
  5. "J&J's Biosense Webster launches Carto Vizigo guiding sheath". MassDevice. 2018-05-08. Retrieved 2021-09-30.
  6. "Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter". DAIC. 2019-07-05. Retrieved 2021-09-30.
  7. "Johnson & Johnson's Cerenovus launches new clot removal devices to treat stroke". MassDevice. 2020-09-14. Retrieved 2021-10-01.
  8. "Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration Catheter | Clinical Research Trial Listing (Acute Ischemic Stroke, NCT04531904)". www.centerwatch.com. Retrieved 2021-10-01.
  9. "Johnson & Johnson's Cerenovus launches new clot removal devices to treat stroke". MassDevice. 2020-09-14. Retrieved 2021-10-01.
  10. "Q&A: The benefits and technology behind mechanical thrombectomy". Med-Tech Innovation. 2021-02-22. Retrieved 2021-10-01.
  11. "Johnson & Johnson's Cerenovus launches new clot removal devices to treat stroke". MassDevice. 2020-09-14. Retrieved 2021-10-01.
  12. Bell, Jamie (2021-07-23). "Cerenovus to unveil new data and showcase stroke care innovations at SNIS 2021". NeuroNews International. Retrieved 2021-10-01.
  13. "DePuy Synthes lands FDA clearance for Velys robotic knee system". MassDevice. 2021-01-20. Retrieved 2021-10-01.
  14. Shetty, Gautam; Khairkar, Shruti (July 2021). "Loading on Attune® fixed-bearing cruciate-substituting total knee implant in knee malalignment during activities of daily living: A finite element analysis". Journal of Orthopaedics. 26: 36–41. doi:10.1016/j.jor.2021.07.002. ISSN 0972-978X. PMC 8280525. PMID 34290486.
  15. "DePuy Synthes Launches ACTIS Total Hip System". ryortho.com. Retrieved 2021-10-01.
  16. "DePuy Synthes launches new shoulder arthroplasty system". www.healio.com. Retrieved 2021-10-01.
  17. Hartwell, Matthew J.; Goldberg, Daniel B.; Moulton, Samuel G.; Zhang, Alan L. (2023-04-01). "Postless Tape Augmentation for Posterior Cruciate Ligament Reconstruction". Arthroscopy Techniques. 12 (4): e575–e582. doi:10.1016/j.eats.2022.12.012. ISSN 2212-6287.
  18. "Miami Orthopedics & Sports Medicine Institute First to use Innovative Device to Treat Long Bone Injuries". Baptist Health South Florida. 2020-09-09. Retrieved 2021-10-01.
  19. Vetalice, Julie A. (2019-11-21). "DePuy Synthes Launches SYMPHONY OCT System". ORTHOWORLD. Retrieved 2024-12-09.
  20. Zhang, Qian; Zhang, Chao; Fang, Xuanyu; Luo, Xu; Guo, Jiwei (2018-08-13). "Biomaterial suture Vicryl Plus reduces wound-related complications". Therapeutics and Clinical Risk Management. 14: 1417–1421. doi:10.2147/TCRM.S164658. PMC 6095114. PMID 30147325.
  21. "J&J's Ethicon touts surgical stapler study". Medical Design and Outsourcing. 2020-08-06. Retrieved 2021-09-30.
  22. "Ethicon launches Stratafix knotless sutures". MassDevice. 2016-08-22. Retrieved 2021-09-30.
  23. "FDA Clears Surgicel Powder Absorbable Hemostat". Medscape. Retrieved 2021-09-30.
  24. "J&J's Alex Gorsky to Step Down as CEO". mddionline.com. 2021-08-20. Retrieved 2022-04-12.
  25. "J&J spends $3.4 billion in cash for Auris Health's lung cancer diagnostics and surgical robots". TechCrunch. 13 February 2019. Retrieved 2022-04-12.
  26. "Johnson & Johnson, Mauna Kea launch study of lung cancer biopsy guidance tool". FierceBiotech. 20 September 2021. Retrieved 2021-09-30.
  27. "J&J's Mentor Wins FDA Nod for MemoryGel Enhance Breast Implant". Medical Product Outsourcing. 2024-12-04. Retrieved 2024-12-09.
  28. Cunningham, Bruce (December 2007). "The Mentor Study on Contour Profile Gel Silicone MemoryGel Breast Implants". Plastic and Reconstructive Surgery. 120 (Supplement 1): 33S–39S. doi:10.1097/01.prs.0000286665.91043.bc. ISSN 0032-1052. PMID 18090812. S2CID 5804537.
  29. "FDA approves J&J's Mentor MemoryGel Xtra silicone breast implants". MassDevice. 2017-04-27. Retrieved 2021-10-01.
  30. "FDA approves J&J's Mentor MemoryGel Xtra silicone breast implants". MassDevice. 2017-04-27. Retrieved 2021-10-01.
  31. "FDA approves J&J's Mentor MemoryGel Xtra silicone breast implants". MassDevice. 2017-04-27. Retrieved 2021-10-01.
  32. "Increasing Demand of Silicone and Saline Breast Aug Market by 2028 with Top Key Players – Allergan, Mentor Worldwide, GC Aesthetics". Stillwater Current. Retrieved 2021-10-01.
  33. Coats, Jade (2 September 2021). "Pupil size matters in presbyopia treatment". Optometry Times Journal. September digital edition 2021. 13 (9). Retrieved 2021-09-30.
  34. "Tecnis Synergy shows good performance at all distances in refractive lens exchange". www.healio.com. Retrieved 2022-04-12.
  35. Guttman Krader, Cheryl (2021-11-12). "Physicians sort out pros and cons of several new IOLs on the market". Digital Edition. Ophthalmology Times: October 15, 2021. 46 (17).
  36. "Dr Rajesh Rajpal Reviews Latest Innovations in Cataract Surgery". AJMC. 11 September 2021. Retrieved 2021-10-01.
  37. "Alcon, Johnson & Johnson to face off in intellectual property dispute". Ophthalmology Times. 17 May 2021. Retrieved 2021-10-01.
  38. "Johnson & Johnson Vision to acquire TearScience". www.healio.com. Retrieved 2021-10-01.
  39. Faktorovich, Ella; Ibach, Mitch (12 October 2019). "30 years of LASIK". Optometry Times Journal. Optometry Times October 2019. 11 (10). Retrieved 2021-09-30.
  40. "Pharmaceutical Products". Content Lab U.S. Retrieved 2022-01-08.
  41. "Biosimilar drugs gain ground, but concerns linger about switching". STAT. 2021-09-21. Retrieved 2021-09-30.
  42. "FDA expands Simponi Aria labeling to include fatigue in RA, PsA". www.healio.com. Retrieved 2021-10-01.
  43. "FDA expands Simponi Aria labeling to include fatigue in RA, PsA". www.healio.com. Retrieved 2021-10-01.
  44. "Stelara and dosage: Strengths, forms, when to use, and more". www.medicalnewstoday.com. 2021-08-15. Retrieved 2021-10-01.
  45. "Study: Guselkumab More Effective Than Secukinumab in Certain Subpopulations". Dermatology Times. 3 September 2021. Retrieved 2021-10-01.
  46. Johnson, Janssen Pharmaceutical Companies of Johnson &. "Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV". www.prnewswire.com (Press release). Retrieved 2021-10-01.
  47. "Amneal Launches Etravirine Tablet Generic for HIV". www.pharmacypracticenews.com. Retrieved 2021-10-01.
  48. "Prezcobix". News-Medical.net. Retrieved 2021-10-01.
  49. "Symtuza". News-Medical.net. Retrieved 2021-10-01.
  50. "The Janssen COVID-19 Vaccine Emergency Use Authorization (EUA) Official Website". www.janssencovid19vaccine.com. Retrieved 2021-09-30.
  51. "Concerta: Dosage, side effects, alternatives, and more". www.medicalnewstoday.com. 2019-09-14. Retrieved 2021-10-01.
  52. "Invega Hafyera Approved for Twice-Yearly Treatment of Schizophrenia". Neurology Advisor. 2021-09-13. Retrieved 2021-10-01.
  53. Monica Holmberg, Pharmd (16 September 2021). "Ponvory From Janssen Pharmaceuticals, Inc". Pharmacy Times. September 2021. 87 (9): 40. Retrieved 2021-10-01.
  54. "Risperidone (Risperdal): Uses, Interactions & Side Effects". Cleveland Clinic. Retrieved 2023-12-04.
  55. "Spravato". News-Medical.net. Retrieved 2021-10-01.
  56. "Topiramate: Uses & Side Effects". Cleveland Clinic. Retrieved 2023-12-04.
  57. "J&J seeks European approval for twice-yearly schizophrenia drug". FiercePharma. 7 December 2020. Retrieved 2021-10-01.
  58. "J&J seeks European approval for twice-yearly schizophrenia drug". FiercePharma. 7 December 2020. Retrieved 2021-10-01.
  59. "Dual Targeting of CDKN2A and PIK3CA May Offer Better Outcomes in Urothelial Carcinoma". Targeted Oncology. 7 September 2021. Retrieved 2021-10-01.
  60. "FDA grants approval to Janssen's Carvykti for multiple myeloma treatment". Pharmaceutical Technology. 2022-03-01. Retrieved 2022-03-02.
  61. "Dacogen". Encyclopedia of Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg. 2009. p. 821. doi:10.1007/978-3-540-47648-1_1505. ISBN 978-3-540-36847-2.
  62. "Summary of opinion: Darzalex,daratumumab". Case Medical Research. 2019-12-13. doi:10.31525/cmr-242ed13. ISSN 2643-4652. S2CID 243064685.
  63. "Important safety update for 'Eprex'". Reactions Weekly (909): 2. July 2002. doi:10.2165/00128415-200209090-00002. ISSN 0114-9954. S2CID 195107338.
  64. "Robust PSA Response and Treatment Adherence of Apalutamide in CRPC Seen with RWE". Targeted Oncology. 10 September 2021. Retrieved 2021-10-01.
  65. "Summary of opinion: Imbruvica,ibrutinib". Case Medical Research. 2019-06-28. doi:10.31525/cmr-1658a62. ISSN 2643-4652. S2CID 242261638.
  66. Bennett, Charles L.; Luminari, Stefano; Nissenson, Allen R.; Tallman, Martin S.; Klinge, Stephen A.; McWilliams, Norene; McKoy, June M.; Kim, Benjamin; Lyons, E. Allison; Trifilio, Steve M.; Raisch, Dennis W.; Evens, Andrew M.; Kuzel, Timothy M.; Schumock, Glen T.; Belknap, Steven M. (2004-09-30). "Pure Red-Cell Aplasia and Epoetin Therapy". New England Journal of Medicine. 351 (14): 1403–1408. doi:10.1056/NEJMoa040528. ISSN 0028-4793.
  67. "US FDA approval tracker: September". Evaluate.com. 2021-10-01. Retrieved 2021-10-01.
  68. RPh, Diana Ernst (2023-08-22). "Talvey Gets Accelerated Approval for Relapsed/Refractory Multiple Myeloma". Oncology Nurse Advisor. Retrieved 2023-12-04.
  69. "Tecvayli: Cost, dosage, side effects, and more". www.medicalnewstoday.com. 2023-04-14. Retrieved 2023-12-04.
  70. "Actelion to buy Ceptaris - if FDA backs its cancer treatment". PMLive. 2013-08-01. Retrieved 2021-10-01.
  71. "Discovery – Velcade®: A New Tool in the Fight against Multiple Myeloma - NCI". www.cancer.gov. 2014-06-30. Retrieved 2023-12-04.
  72. "FDA clears J&J's chemotherapy for certain soft tissue sarcomas". Reuters. 2015-10-23. Retrieved 2021-10-01.
  73. "Zytiga interaction". The Pharmaceutical Journal. 2014. doi:10.1211/pj.2014.20065701. ISSN 2053-6186.
  74. Singh, Vandana (2021-09-27). "J&J's Xarelto Tops Aspirin With Fewer Blood Clots In Pediatric Patients". Benzinga. Retrieved 2021-10-01.
  75. "Diabetes Drug Gets FDA Warning Due to Amputation Risk". WebMD. Retrieved 2021-10-01.
  76. "SGLT2 inhibitors for diabetes". www.medicalnewstoday.com. 2021-02-26. Retrieved 2021-10-01.
  77. Wexler, Marisa (September 2021). "Uptravi Found to Reduce Risk of PAH Disease Progression by Half". Retrieved 2021-09-30.
  78. Pena, Ana (25 November 2019). "Actelion Pulls Requests to Treat Inoperable CTEPH with Opsumit, Will Gather More Data". Retrieved 2021-10-01.
  79. Silva, Joana Cavaco. "Pulmonary Hypertension Therapy Veletri Improves' Patients Functioning". Retrieved 2021-10-01.
  80. Bryson, Steve (5 January 2021). "Tracleer for Digital Ulcers Lowers PH Risk in Scleroderma, Study Finds". Retrieved 2021-10-01.
  81. "FDA Approvals: Ventavis, Kepivance, Captique". Medscape. Retrieved 2021-09-30.
Category: